Ensysce Historical Cash Flow
| ENSC Stock | USD 0.59 0.07 10.61% |
Analysis of Ensysce Biosciences cash flow over time is an excellent tool to project Ensysce Biosciences future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Capital Expenditures of 2.1 or Total Cash From Financing Activities of 8.3 M as it is a great indicator of Ensysce Biosciences ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Ensysce Biosciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Ensysce Biosciences is a good buy for the upcoming year.
Ensysce |
About Ensysce Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Ensysce balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Ensysce's non-liquid assets can be easily converted into cash.
Ensysce Biosciences Cash Flow Chart
Add Fundamental
Free Cash Flow
The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Most accounts from Ensysce Biosciences' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Ensysce Biosciences current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Ensysce Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. For information on how to trade Ensysce Stock refer to our How to Trade Ensysce Stock guide.At present, Ensysce Biosciences' Other Cashflows From Investing Activities is projected to increase significantly based on the last few years of reporting. The current year's Net Borrowings is expected to grow to about 16.8 M, whereas Sale Purchase Of Stock is forecasted to decline to about 1.5 M.
Ensysce Biosciences cash flow statement Correlations
Click cells to compare fundamentals
Ensysce Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Ensysce Biosciences cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Sale Purchase Of Stock | (11.6M) | (184.8M) | 803.1B | 3.8M | 1.6M | 1.5M | |
| Change In Cash | (597.2K) | (147.3K) | 12.1M | (9.1M) | (2.0M) | (1.9M) | |
| Free Cash Flow | 11.0M | (1.2M) | (8.2M) | (17.9M) | (10.8M) | (10.2M) | |
| Change In Working Capital | 2.5M | 185.1K | (1.3M) | 5.5M | (947.1K) | (899.7K) | |
| Total Cashflows From Investing Activities | 838.6K | 11.9M | 183.4M | 4.5K | 5.2K | 5.4K | |
| Other Cashflows From Financing Activities | 100K | 20.0 | 14.2M | 7.3M | (899.5K) | (944.5K) | |
| Other Non Cash Items | 8.2M | 997.5K | 7.5M | (233.4K) | (411.9K) | (391.3K) | |
| Total Cash From Operating Activities | 11.0M | (1.2M) | (8.2M) | (17.9M) | (10.8M) | (10.2M) | |
| Net Income | 366.0K | (160.9K) | (29.1M) | (24.2M) | (10.6M) | (11.2M) | |
| Total Cash From Financing Activities | (11.0M) | 1.1M | 20.3M | 8.8M | 8.8M | 8.3M | |
| End Period Cash Flow | 1.1M | 194.2K | 12.3M | 3.1M | 1.1M | 1.1M | |
| Other Cashflows From Investing Activities | 838.6K | 11.9M | 183.4M | 4.5K | 5.2K | 5.4K | |
| Begin Period Cash Flow | 1.7M | 341.5K | 194.2K | 12.3M | 3.1M | 3.6M | |
| Change To Account Receivables | (173.6K) | 173.6K | (441.7K) | 164.9K | 179.3K | 188.2K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Ensysce Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ensysce Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ensysce Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ensysce Biosciences Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Ensysce Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. For information on how to trade Ensysce Stock refer to our How to Trade Ensysce Stock guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ensysce Biosciences. If investors know Ensysce will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ensysce Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.94) | Revenue Per Share 0.274 | Quarterly Revenue Growth (0.63) | Return On Assets (1.32) | Return On Equity (4.28) |
The market value of Ensysce Biosciences is measured differently than its book value, which is the value of Ensysce that is recorded on the company's balance sheet. Investors also form their own opinion of Ensysce Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Ensysce Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ensysce Biosciences' market value can be influenced by many factors that don't directly affect Ensysce Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ensysce Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ensysce Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ensysce Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.